Active-ingredient Dossier
Simvastatin
Active-ingredient Dossier for Simvastatin (statin). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: APO-EZETIMIBE/SIMVASTATIN
- Brand: LIPEX
- Brand: ZIMSTAT
- Brand: ZIMYBE
- Brand: AKM-EZETIMIBE
- Brand: EZETIMIBE/SIMVASTATIN SANDOZ
- Therapeutic area: Cardiology
What is
Simvastatin Simvastatin is a statin.
Australian brands containing
Simvastatin — LIPEX — SIMVAR — ZIMSTAT — APO-EZETIMIBE/SIMVASTATIN — APO-SIMVASTATIN — EZETORIN — SIMVASTATIN SANDOZ — SIMVASTATIN-TIH — SIMVASTATIN-WGR — ZOCOR
Therapeutic areas
Simvastatin is registered in Neurology (13 brands) and Cardiology (6 brands).
Sponsor landscape
Simvastatin is marketed by Arrotex Pharmaceuticals, Torrent, Alphapharm, Organon Pharma, Generic Health, and Sandoz.
PBS and regulatory activity
Three brands containing simvastatin have PBS-listed items, with the latest PBS schedule date of 1 May 2026. Government expenditure on simvastatin was approximately $51.8 million in the 2016–17 financial year.